Stay updated on TAPUR Study: Targeted Drug Clinical Trial
Sign up to get notified when there's something new on the TAPUR Study: Targeted Drug Clinical Trial page.

Latest updates to the TAPUR Study: Targeted Drug Clinical Trial page
- Check4 days agoChange DetectedThe page now shows a 403 Forbidden error instead of loading the study record, indicating that access to the URL is restricted.SummaryDifference0.5%

- Check11 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the study details and navigation with an error message. This indicates the content is unavailable at this URL.SummaryDifference23%

- Check18 days agoChange DetectedUI text changes: 'Find contact information' now appears (instead of 'Find Contact Information'). The revision tag changed from v3.6.6 to v3.7.0, indicating a new release without altering study data.SummaryDifference0.0%

- Check32 days agoChange DetectedThe study record now shows additional recruitment sites (including Puerto Rico locations) and updated point-of-contact details, while certain therapeutic arms (regorafenib and palbociclib) have been removed from the arms section.SummaryDifference1%

- Check53 days agoChange DetectedThe page’s revision label was updated from v3.6.4 to v3.6.5, indicating a minor version bump to the page.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded a new publication entry for Veljovich et al. on Palbociclib in ovarian cancer with CDKN2A alterations to the Publications section. The page revision was updated from v3.6.3 to v3.6.4.SummaryDifference0.0%

Stay in the know with updates to TAPUR Study: Targeted Drug Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAPUR Study: Targeted Drug Clinical Trial page.